The study uncovers mechanisms linking Down syndrome to leukemia, emphasizing the role of oxidative stress and genetic alterations in fetal blood development.

Younger and older fathers could be more likely to have a baby with Down syndrome, according to an international analysis of ...

In this new episode of Aha! with JAHA, Dr. Laxmi Mehta interviews Dr. Jennifer Peterson (Johns Hopkins University School of Nursing) about “Trisomy 21 and Congenital Heart Disease: Impact on Health ...

Children with Down’s syndrome have a 150-fold increased risk of developing leukaemia than those without the condition. Now, ...

Cell-free DNA test during pregnancy is a non-invasive test that screens for common chromosomal disorders like Down syndrome.

Statement highlights include: Trisomy 21, also known as Down syndrome, is a genetic condition that occurs when a person has an extra copy of chromosome 21. According to the American Heart ...

Antenatal diagnosis of Trisomy 13 is often made by karyotyping. This is typically performed after an assessment of risk for a chromosomal disorder is made by the maternal healthcare provider.

The scientific statement, "Trisomy 21 and Congenital Heart Disease: Impact on Health and Functional Outcomes from Birth Through Adolescence," is published today (Sept. 12) in the Journal of the ...

The recurrence risk with trisomy is 1% to 2% or the maternal age risk, whichever is greater. [2] There is a recurrence risk of 5% to 10% for an affected live-born infant in cases when a parent has ...

Women with a ‘high-chance’ of trisomy 21, 18 or 13 (≥1:150) were offered the choice of no further testing, NIPT or invasive testing, in line with the screening pathway recommended by the UK National ...

Aelis Farma (ISIN: FR0014007ZB4 - ticker: AELIS), a clinical-stage biopharmaceutical company focused on developing treatments ...